
VERABAND™
-
Physicians need a way of collecting longitudinal objective data about patient’s physical function between clinic visits to drive clinical decision making.
-
Through the NIH customer discovery program, we also learned that existing technologies impose unacceptable technical burden on patients, doctors and clinics making then unsuitable for routine clinical care.
-
To meet this need, we are developing the VERABAND™, the first burden-free, single-use wearable that provides a simple clinical summary containing objective evidence of the changes in burden a patient is experiencing due to their chronic pain treatment regime.

Key milestones
-
Patents and Trademark Filed (2021)
-
FDA Pre-submission Meeting (2022)
-
Completed Initial Prototypes & proof of concept (2022)
-
Human Factors Study (2022)
-
Competitor Equivalence Study (May-June 2023)
-
510(k) Submission (July 2023)
-
3-year Useability Study (2024 - 2026)
-
Production to Volume Ramp-up (2024 - 2026)